Company Filing History:
Years Active: 2009-2021
Title: The Innovations of Pamela Paris
Introduction
Pamela Paris is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of medical technology, particularly in the area of prostate cancer research. With a total of 2 patents, her work focuses on improving patient outcomes through innovative methods and systems.
Latest Patents
One of her latest patents is titled "Determining Risk of Prostate Tumor Aggressiveness." This invention relates to methods, computer products, computer-implemented methods, and systems for predicting the probability or risk of prostate cancer recurrence and tumor aggressiveness in a patient. The method is based, in part, on the patient's risk profile that includes the presence and degree of specific copy number variations and predictive clinical factors. These methods and systems can be used to aid in treatment selection. Another significant patent is "Biomarkers for Prostate Cancer Metastasis." This invention provides genomic markers for determining the predisposition of prostate cancer to become metastasized.
Career Highlights
Pamela Paris is affiliated with the University of California, where she continues to advance her research and innovations. Her work has garnered attention for its potential to significantly impact the treatment and management of prostate cancer.
Collaborations
She has collaborated with notable colleagues, including Colin Conrad Collins and Matthew Cooperberg, to further enhance her research efforts and contribute to the scientific community.
Conclusion
Pamela Paris is a pioneering inventor whose work in prostate cancer research is making a difference in the medical field. Her innovative patents reflect her commitment to improving patient care and advancing medical technology.